---
annotation-target: 1-s2.0-S0006497122010734-main.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-16T13:04:59.208Z","updated":"2022-09-16T13:04:59.208Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":184,"end":213},{"type":"TextQuoteSelector","exact":"immune and metabolic networks","prefix":" promotes relapse by disrupting ","suffix":" afterallogeneic stem cell trans"}]}]}
>```
>%%
>*%%PREFIX%%promotes relapse by disrupting%%HIGHLIGHT%% ==immune and metabolic networks== %%POSTFIX%%afterallogeneic stem cell trans*
>%%LINK%%[[#^a25pf5uvynu|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^a25pf5uvynu


>%%
>```annotation-json
>{"created":"2022-09-16T13:05:25.696Z","updated":"2022-09-16T13:05:25.696Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":6598,"end":6732},{"type":"TextQuoteSelector","exact":"zithromycin dampens anti-tumor immune response by disrupting T cell functions through inhibition of energy metabolism in immune cells.","prefix":" randomized-placebo trial.  •  A","suffix":"  Abstract (149 words): Administ"}]}]}
>```
>%%
>*%%PREFIX%%randomized-placebo trial.  •  A%%HIGHLIGHT%% ==zithromycin dampens anti-tumor immune response by disrupting T cell functions through inhibition of energy metabolism in immune cells.== %%POSTFIX%%Abstract (149 words): Administ*
>%%LINK%%[[#^e7dcxytsya4|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^e7dcxytsya4


>%%
>```annotation-json
>{"created":"2022-09-16T13:06:19.325Z","updated":"2022-09-16T13:06:19.325Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":7149,"end":7745},{"type":"TextQuoteSelector","exact":". We used multi-omics on patients’ samples to decipher immune alterations  associated  with  azithromycin  intake  and  post-transplant  relapsed  malignancies. Azithromycin  was  associated  with  a  network  of  altered  energy  metabolism  pathways  and immune subsets, including T cells biased toward immunomodulatory and exhausted profiles. In vitro, azithromycin exposure inhibited T cells cytotoxicity against tumor cells and impaired T cells  metabolism  through  glycolysis  inhibition,  mitochondrial  genes  downregulation,  and immunomodulatory  genes  upregulation,  notably  SOCS1. ","prefix":" mortality after transplantation","suffix":" These  results  highlight  that"}]}]}
>```
>%%
>*%%PREFIX%%mortality after transplantation%%HIGHLIGHT%% ==. We used multi-omics on patients’ samples to decipher immune alterations  associated  with  azithromycin  intake  and  post-transplant  relapsed  malignancies. Azithromycin  was  associated  with  a  network  of  altered  energy  metabolism  pathways  and immune subsets, including T cells biased toward immunomodulatory and exhausted profiles. In vitro, azithromycin exposure inhibited T cells cytotoxicity against tumor cells and impaired T cells  metabolism  through  glycolysis  inhibition,  mitochondrial  genes  downregulation,  and immunomodulatory  genes  upregulation,  notably  SOCS1.== %%POSTFIX%%These  results  highlight  that*
>%%LINK%%[[#^ogjy8r28lyr|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^ogjy8r28lyr


>%%
>```annotation-json
>{"created":"2022-09-16T13:07:18.075Z","updated":"2022-09-16T13:07:18.075Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":8401,"end":9169},{"type":"TextQuoteSelector","exact":"  Azithromycin  was  shown  to  prevent  BOS  following  lung transplantation8. These observations led us to investigate if azithromycin could prevent BOS in a multicenter, randomized, placebo-controlled, double-blind, phase 3 study (ALLOZITHRO trial). Unexpectedly,  azithromycin  did  not  efficiently prevent  BOS,  and was associated with higher mortality due to an increased risk of relapse (hazard ratio [HR]=1.7, p=0.002). This led to an early  interruption  of  the  study9  and  both  a  Food  and  Drug  Administration  and  European Medicines  Agency  warnings  about  azithromycin  use  after  allo-HSCT10.  In  a  multicenter retrospective setting, azithromycin treatment for BOS after HSCT was also associated with a higher risk of secondary neoplasms11.","prefix":"ciated  with  poor  outcomes5–7.","suffix":" Anti-tumoral  effects  of  allo"}]}]}
>```
>%%
>*%%PREFIX%%ciated  with  poor  outcomes5–7.%%HIGHLIGHT%% ==Azithromycin  was  shown  to  prevent  BOS  following  lung transplantation8. These observations led us to investigate if azithromycin could prevent BOS in a multicenter, randomized, placebo-controlled, double-blind, phase 3 study (ALLOZITHRO trial). Unexpectedly,  azithromycin  did  not  efficiently prevent  BOS,  and was associated with higher mortality due to an increased risk of relapse (hazard ratio [HR]=1.7, p=0.002). This led to an early  interruption  of  the  study9  and  both  a  Food  and  Drug  Administration  and  European Medicines  Agency  warnings  about  azithromycin  use  after  allo-HSCT10.  In  a  multicenter retrospective setting, azithromycin treatment for BOS after HSCT was also associated with a higher risk of secondary neoplasms11.== %%POSTFIX%%Anti-tumoral  effects  of  allo*
>%%LINK%%[[#^pgrk5s86xi|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^pgrk5s86xi


>%%
>```annotation-json
>{"created":"2022-09-16T13:08:10.930Z","updated":"2022-09-16T13:08:10.930Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":9993,"end":10138},{"type":"TextQuoteSelector","exact":"e applied mass cytometry and non-targeted metabolomics, to determine the impact of azithromycin on immune subsets and the metabolome of patients.","prefix":"relapse after allo-4/30  HSCT. W","suffix":" This approach revealed that azi"}]}]}
>```
>%%
>*%%PREFIX%%relapse after allo-4/30  HSCT. W%%HIGHLIGHT%% ==e applied mass cytometry and non-targeted metabolomics, to determine the impact of azithromycin on immune subsets and the metabolome of patients.== %%POSTFIX%%This approach revealed that azi*
>%%LINK%%[[#^2yeoy85depv|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^2yeoy85depv


>%%
>```annotation-json
>{"created":"2022-09-16T13:09:26.593Z","updated":"2022-09-16T13:09:26.593Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":10286,"end":11026},{"type":"TextQuoteSelector","exact":". Considering that azithromycin could alter host or bacteria metabolism, we then  examined  the  plasma  and  cellular  metabolomes19,20.  Integration  of  biological  variables associated with azithromycin intake and clinical data highlighted an immuno-metabolic network associated with tumor relapse after allo-HSCT. We next uncovered the inhibitory properties of azithromycin  on  major  T cells  functions,  including  proliferation,  cytokines  production, cytotoxicity  against  leukemic  targets.  Finally,  we  studied  how  azithromycin  impairs  T cells metabolism during activation through glycolysis inhibition, downregulation of mitochondrial and pro-inflammatory gene expression, and upregulation of immune suppressive genes. ","prefix":"ation of their functional states","suffix":"     5/30  METHODS Study design "}]}]}
>```
>%%
>*%%PREFIX%%ation of their functional states%%HIGHLIGHT%% ==. Considering that azithromycin could alter host or bacteria metabolism, we then  examined  the  plasma  and  cellular  metabolomes19,20.  Integration  of  biological  variables associated with azithromycin intake and clinical data highlighted an immuno-metabolic network associated with tumor relapse after allo-HSCT. We next uncovered the inhibitory properties of azithromycin  on  major  T cells  functions,  including  proliferation,  cytokines  production, cytotoxicity  against  leukemic  targets.  Finally,  we  studied  how  azithromycin  impairs  T cells metabolism during activation through glycolysis inhibition, downregulation of mitochondrial and pro-inflammatory gene expression, and upregulation of immune suppressive genes.== %%POSTFIX%%5/30  METHODS Study design*
>%%LINK%%[[#^h18nk6ipu9|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^h18nk6ipu9


>%%
>```annotation-json
>{"created":"2022-09-16T13:10:25.314Z","updated":"2022-09-16T13:10:25.314Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":12352,"end":12532},{"type":"TextQuoteSelector","exact":"Analysis pipeline  are  available  on  Git  repositories:  https://gitlab.com/nivall/azimut-blood; https://gitlab.com/nivall/azimut-in-vitro; https://gitlab.com/nivall/azimutscrna ","prefix":"EO  GSE197658  and  GSE208399.  ","suffix":"   6/30  RESULTS   Cohort descri"}]}]}
>```
>%%
>*%%PREFIX%%EO  GSE197658  and  GSE208399.%%HIGHLIGHT%% ==Analysis pipeline  are  available  on  Git  repositories:  https://gitlab.com/nivall/azimut-blood; https://gitlab.com/nivall/azimut-in-vitro; https://gitlab.com/nivall/azimutscrna== %%POSTFIX%%6/30  RESULTS   Cohort descri*
>%%LINK%%[[#^6g4ir7x0uu7|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^6g4ir7x0uu7


>%%
>```annotation-json
>{"created":"2022-09-16T13:13:42.311Z","updated":"2022-09-16T13:13:42.311Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":13325,"end":13414},{"type":"TextQuoteSelector","exact":"We first ruled out that azithromycin could increase tumor cell proliferation or survival.","prefix":"igher anti-inflammatory subsets ","suffix":" Fourteen AML cell lines and pri"}]}]}
>```
>%%
>*%%PREFIX%%igher anti-inflammatory subsets%%HIGHLIGHT%% ==We first ruled out that azithromycin could increase tumor cell proliferation or survival.== %%POSTFIX%%Fourteen AML cell lines and pri*
>%%LINK%%[[#^q3ooy8khha|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^q3ooy8khha


>%%
>```annotation-json
>{"created":"2022-09-16T13:14:12.629Z","updated":"2022-09-16T13:14:12.629Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":13656,"end":13729},{"type":"TextQuoteSelector","exact":"e  then  focused  on  circulating  immune  cells  in  patients’  samples.","prefix":"upplemental Figure S2 and S3). W","suffix":"  To  identify  main PBMC  cell "}]}]}
>```
>%%
>*%%PREFIX%%upplemental Figure S2 and S3). W%%HIGHLIGHT%% ==e  then  focused  on  circulating  immune  cells  in  patients’  samples.== %%POSTFIX%%To  identify  main PBMC  cell*
>%%LINK%%[[#^fkbv8ukb3e|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^fkbv8ukb3e


>%%
>```annotation-json
>{"created":"2022-09-16T13:14:53.619Z","updated":"2022-09-16T13:14:53.619Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":14061,"end":14167},{"type":"TextQuoteSelector","exact":" We found that patients included in the azithromycin arm were associated with a lower abundance of T cells","prefix":"pplemental Figure S4, Table S2).","suffix":" (p=0.024), while no difference "}]}]}
>```
>%%
>*%%PREFIX%%pplemental Figure S4, Table S2).%%HIGHLIGHT%% ==We found that patients included in the azithromycin arm were associated with a lower abundance of T cells== %%POSTFIX%%(p=0.024), while no difference*
>%%LINK%%[[#^n5sfnx9i3ma|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^n5sfnx9i3ma


>%%
>```annotation-json
>{"created":"2022-09-16T13:15:51.888Z","updated":"2022-09-16T13:15:51.888Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":14260,"end":15109},{"type":"TextQuoteSelector","exact":" Next, we compared the frequency of phenotypical clusters among these subsets. Azithromycin-treated patients were characterized by higher central memory (CM) and effector memory (EM) CD4+ T cells with a Th2 profile defined by CXCR3-CCR4+ (p=0.045 and p=0.010, respectively). A higher frequency of CCR5-FoxP3lo regulatory T cells (Tregs) was also found in azithromycin-treated patients (p=0.003). Azithromycin treatment was associated with a higher frequency of activated CM CD8+ cells characterized by high HLA-DR, CD38, and PD-1  expression,  suggesting  an  exhausted  phenotype  (p=0.033).  Finally,  azithromycin  intake was  associated  with  lower  switched  memory  CD5-CXCR3-CCR7+  B  cells  (p=0.033),  with  a higher abundance of immature CD56hiCCR5lo NK cells (p=0.003) and lower frequency of cluster 40 among unidentified cells (p=0.016)","prefix":"30  myeloid lineage (Figure 2D).","suffix":" (Figure 2E-F, Supplemental Figu"}]}]}
>```
>%%
>*%%PREFIX%%30  myeloid lineage (Figure 2D).%%HIGHLIGHT%% ==Next, we compared the frequency of phenotypical clusters among these subsets. Azithromycin-treated patients were characterized by higher central memory (CM) and effector memory (EM) CD4+ T cells with a Th2 profile defined by CXCR3-CCR4+ (p=0.045 and p=0.010, respectively). A higher frequency of CCR5-FoxP3lo regulatory T cells (Tregs) was also found in azithromycin-treated patients (p=0.003). Azithromycin treatment was associated with a higher frequency of activated CM CD8+ cells characterized by high HLA-DR, CD38, and PD-1  expression,  suggesting  an  exhausted  phenotype  (p=0.033).  Finally,  azithromycin  intake was  associated  with  lower  switched  memory  CD5-CXCR3-CCR7+  B  cells  (p=0.033),  with  a higher abundance of immature CD56hiCCR5lo NK cells (p=0.003) and lower frequency of cluster 40 among unidentified cells (p=0.016)== %%POSTFIX%%(Figure 2E-F, Supplemental Figu*
>%%LINK%%[[#^jdk8p6nfqk8|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^jdk8p6nfqk8


>%%
>```annotation-json
>{"created":"2022-09-16T13:16:04.162Z","updated":"2022-09-16T13:16:04.162Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":15222,"end":15346},{"type":"TextQuoteSelector","exact":"We  then  studied  T cell  functional  profiles  with  14  additional  functional  markers  using  the FlowSOM algorithm. We","prefix":"th exhausted T cells phenotypes ","suffix":" identified 25 clusters represen"}]}]}
>```
>%%
>*%%PREFIX%%th exhausted T cells phenotypes%%HIGHLIGHT%% ==We  then  studied  T cell  functional  profiles  with  14  additional  functional  markers  using  the FlowSOM algorithm. We== %%POSTFIX%%identified 25 clusters represen*
>%%LINK%%[[#^a74ewvjyb0d|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^a74ewvjyb0d


>%%
>```annotation-json
>{"created":"2022-09-16T13:16:31.904Z","updated":"2022-09-16T13:16:31.904Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":15439,"end":15769},{"type":"TextQuoteSelector","exact":"Three  main  profiles  emerged:  (i)  activated  cells  characterized  by  the expression  of  granzyme  B,  Eomes  or  T-bet;  (ii)  naïve  cells  characterized  by  low  levels  of expression of most functional markers; and (iii) exhausted cells characterized by higher levels of TOX, PD-1, ICOS, CTLA-4, 4-1BB, LAG-3 and TIM-3 ","prefix":" states of cells  (Figure 3A).  ","suffix":"(Figure 3A).  We  next  compared"}]}]}
>```
>%%
>*%%PREFIX%%states of cells  (Figure 3A).%%HIGHLIGHT%% ==Three  main  profiles  emerged:  (i)  activated  cells  characterized  by  the expression  of  granzyme  B,  Eomes  or  T-bet;  (ii)  naïve  cells  characterized  by  low  levels  of expression of most functional markers; and (iii) exhausted cells characterized by higher levels of TOX, PD-1, ICOS, CTLA-4, 4-1BB, LAG-3 and TIM-3== %%POSTFIX%%(Figure 3A).  We  next  compared*
>%%LINK%%[[#^7t186s2wsi5|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^7t186s2wsi5


>%%
>```annotation-json
>{"created":"2022-09-16T13:17:06.599Z","updated":"2022-09-16T13:17:06.599Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":15783,"end":15910},{"type":"TextQuoteSelector","exact":"We  next  compared  abundances  of  functional  clusters  among  phenotypical  clusters  in azithromycin and placebo patients. ","prefix":", LAG-3 and TIM-3 (Figure 3A).  ","suffix":"We identified four T cells subse"}]}]}
>```
>%%
>*%%PREFIX%%, LAG-3 and TIM-3 (Figure 3A).%%HIGHLIGHT%% ==We  next  compared  abundances  of  functional  clusters  among  phenotypical  clusters  in azithromycin and placebo patients.== %%POSTFIX%%We identified four T cells subse*
>%%LINK%%[[#^f4y9sd5o09|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^f4y9sd5o09


>%%
>```annotation-json
>{"created":"2022-09-16T13:17:25.306Z","updated":"2022-09-16T13:17:25.306Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":16547,"end":16863},{"type":"TextQuoteSelector","exact":"Together  these  results  highlight  that,  patients  treated  with  azithromycin  were characterized  by  lower  T  cells  abundance  and  were  biased  toward  immunomodulatory  Th2 response, with increased FoxP3+ regulatory T cells and exhausted phenotypes characterized by the expression of TOX, PD-1, and TIGIT.","prefix":"ents (p=0.039) (Figure 3A-B).   ","suffix":"  Azithromycin is associated wit"}]}]}
>```
>%%
>*%%PREFIX%%ents (p=0.039) (Figure 3A-B).%%HIGHLIGHT%% ==Together  these  results  highlight  that,  patients  treated  with  azithromycin  were characterized  by  lower  T  cells  abundance  and  were  biased  toward  immunomodulatory  Th2 response, with increased FoxP3+ regulatory T cells and exhausted phenotypes characterized by the expression of TOX, PD-1, and TIGIT.== %%POSTFIX%%Azithromycin is associated wit*
>%%LINK%%[[#^kq5w90wyo0a|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^kq5w90wyo0a


>%%
>```annotation-json
>{"created":"2022-09-16T13:17:56.973Z","updated":"2022-09-16T13:17:56.973Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":16946,"end":17367},{"type":"TextQuoteSelector","exact":"We  then  explored  if  azithromycin  intake  could  impact  plasma  metabolome,  considering  that azithromycin  could  alter  host-  or  microbiota-related  metabolism19,23.  We  studied  metabolites from  frozen  plasma  and  dried  white  blood  cells  pellets  to  uncover  both  circulating  and intracellular metabolomic profiles. 853 and 352 metabolites were studied in plasma and dried cell pellets, respectively","prefix":"l energy metabolism metabolites ","suffix":" (Supplemental Figure S7).  In  "}]}]}
>```
>%%
>*%%PREFIX%%l energy metabolism metabolites%%HIGHLIGHT%% ==We  then  explored  if  azithromycin  intake  could  impact  plasma  metabolome,  considering  that azithromycin  could  alter  host-  or  microbiota-related  metabolism19,23.  We  studied  metabolites from  frozen  plasma  and  dried  white  blood  cells  pellets  to  uncover  both  circulating  and intracellular metabolomic profiles. 853 and 352 metabolites were studied in plasma and dried cell pellets, respectively== %%POSTFIX%%(Supplemental Figure S7).  In*
>%%LINK%%[[#^ls6vr1hxczh|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^ls6vr1hxczh


>%%
>```annotation-json
>{"created":"2022-09-16T13:18:35.103Z","updated":"2022-09-16T13:18:35.103Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":18284,"end":18405},{"type":"TextQuoteSelector","exact":"e then explored the intracellular metabolome and identified 10 significantly different metabolites between the two groups","prefix":"re 4A, Supplemental Table S4). W","suffix":" (Figure 4B, Supplemental Table "}]}]}
>```
>%%
>*%%PREFIX%%re 4A, Supplemental Table S4). W%%HIGHLIGHT%% ==e then explored the intracellular metabolome and identified 10 significantly different metabolites between the two groups== %%POSTFIX%%(Figure 4B, Supplemental Table*
>%%LINK%%[[#^ucvlgpfueq9|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^ucvlgpfueq9


>%%
>```annotation-json
>{"created":"2022-09-16T13:19:26.033Z","updated":"2022-09-16T13:19:26.033Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":18829,"end":19740},{"type":"TextQuoteSelector","exact":"Altogether  these  results  underline  changes  in  pathways  converging  to  acetyl-CoA synthesis from mitochondrial beta-oxidation through enrichment in acyl-carnitine and MC-FA pathways for its use in OXPHOS. CoA was recently found to enhance CD8+ Tc22 anti-tumoral functions26. Here, the precursor of CoA, pantothenate, was increased in the azithromycin group. This may be related to the metabolite accumulation because of lower incorporation in CoA as reported  when  inhibiting  pantothenate  kinase  (PANK)27.  Supporting  this  hypothesis,  acyl-carnitine metabolites were higher in azithromycin patients as observed within PANK inhibited hepatocytes (Supplemental Table S3)27. Additionally, the enrichment in plasmalogens suggests that  immune-regulatory  pathways  are  involved  in  the  azithromycin  effect  as  higher  levels  of plasmalogens are associated with post-transplant immune tolerance28","prefix":"ure 4B, Supplemental Table S6). ","suffix":".  Variables associated with azi"}]}]}
>```
>%%
>*%%PREFIX%%ure 4B, Supplemental Table S6).%%HIGHLIGHT%% ==Altogether  these  results  underline  changes  in  pathways  converging  to  acetyl-CoA synthesis from mitochondrial beta-oxidation through enrichment in acyl-carnitine and MC-FA pathways for its use in OXPHOS. CoA was recently found to enhance CD8+ Tc22 anti-tumoral functions26. Here, the precursor of CoA, pantothenate, was increased in the azithromycin group. This may be related to the metabolite accumulation because of lower incorporation in CoA as reported  when  inhibiting  pantothenate  kinase  (PANK)27.  Supporting  this  hypothesis,  acyl-carnitine metabolites were higher in azithromycin patients as observed within PANK inhibited hepatocytes (Supplemental Table S3)27. Additionally, the enrichment in plasmalogens suggests that  immune-regulatory  pathways  are  involved  in  the  azithromycin  effect  as  higher  levels  of plasmalogens are associated with post-transplant immune tolerance28== %%POSTFIX%%.  Variables associated with azi*
>%%LINK%%[[#^i4utgj1ys7p|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^i4utgj1ys7p


>%%
>```annotation-json
>{"created":"2022-09-16T13:19:52.646Z","updated":"2022-09-16T13:19:52.646Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":19822,"end":20092},{"type":"TextQuoteSelector","exact":"To study the interactions between variables significantly associated with treatment groups and determine whether these variables were also associated with relapse, we studied patients with malignancies  for  which  we  had  all  biological  data  (multi-omics  cohort)  ","prefix":"re also associated with relapse ","suffix":"(Figure 1, 10/30  Supplemental T"}]}]}
>```
>%%
>*%%PREFIX%%re also associated with relapse%%HIGHLIGHT%% ==To study the interactions between variables significantly associated with treatment groups and determine whether these variables were also associated with relapse, we studied patients with malignancies  for  which  we  had  all  biological  data  (multi-omics  cohort)== %%POSTFIX%%(Figure 1, 10/30  Supplemental T*
>%%LINK%%[[#^y9kt31rectk|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^y9kt31rectk


>%%
>```annotation-json
>{"created":"2022-09-16T13:20:37.163Z","updated":"2022-09-16T13:20:37.163Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":20486,"end":20794},{"type":"TextQuoteSelector","exact":"We  first determined if differences associated with azithromycin intake were more pronounced in patients who  relapsed  (Supplemental  Figure S8).  Immune  subsets  and  metabolites  whose  variations were associated with azithromycin intake were also analyzed individually for their association with relapse","prefix":" 95%CI  [1.10-3.02],  p=0.02).  ","suffix":" (Supplemental Table S7). Since "}]}]}
>```
>%%
>*%%PREFIX%%95%CI  [1.10-3.02],  p=0.02).%%HIGHLIGHT%% ==We  first determined if differences associated with azithromycin intake were more pronounced in patients who  relapsed  (Supplemental  Figure S8).  Immune  subsets  and  metabolites  whose  variations were associated with azithromycin intake were also analyzed individually for their association with relapse== %%POSTFIX%%(Supplemental Table S7). Since*
>%%LINK%%[[#^jwldgpydyrr|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^jwldgpydyrr


>%%
>```annotation-json
>{"created":"2022-09-16T13:21:43.523Z","updated":"2022-09-16T13:21:43.523Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":20820,"end":20973},{"type":"TextQuoteSelector","exact":"Since these variables may be associated with relapse in a multivariate manner, we used principal  component  analysis  to  perform  dimension  reduction ","prefix":"elapse (Supplemental Table S7). ","suffix":" (Figure 4C,  Supplemental Figur"}]}]}
>```
>%%
>*%%PREFIX%%elapse (Supplemental Table S7).%%HIGHLIGHT%% ==Since these variables may be associated with relapse in a multivariate manner, we used principal  component  analysis  to  perform  dimension  reduction== %%POSTFIX%%(Figure 4C,  Supplemental Figur*
>%%LINK%%[[#^7nkageimp8j|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^7nkageimp8j


>%%
>```annotation-json
>{"created":"2022-09-16T13:22:50.178Z","updated":"2022-09-16T13:22:50.178Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":22034,"end":22174},{"type":"TextQuoteSelector","exact":" Interestingly, one of the first contributors was white blood cells intracellular 2,3-diphosphoglycerate, a metabolite involved in glycolysi","prefix":" 10)  in  CM  CD8+ (cluster 36).","suffix":"s. Enriched plasmatic pathways i"}]}]}
>```
>%%
>*%%PREFIX%%10)  in  CM  CD8+ (cluster 36).%%HIGHLIGHT%% ==Interestingly, one of the first contributors was white blood cells intracellular 2,3-diphosphoglycerate, a metabolite involved in glycolysi== %%POSTFIX%%s. Enriched plasmatic pathways i*
>%%LINK%%[[#^vakvfl2p1io|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^vakvfl2p1io


>%%
>```annotation-json
>{"created":"2022-09-16T13:23:43.991Z","updated":"2022-09-16T13:23:43.991Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":22214,"end":23404},{"type":"TextQuoteSelector","exact":"11/30  (i)  energy  metabolism:  Fatty  Acid  Dicarboxylate,  CoA  Metabolism,  (ii)  immunomodulator mechanisms:  pregnenolone  steroids,  primary  bile  acid,  plasmalog en  and  (iii)  purine  and pyrimidine  metabolism  (Supplemental  Figure S10A).  In  cells,  most  enriched  metabolomic pathways  also  encompassed  energy  metabolism:  MC-FA,  and  dinucleotides  (Supplemental Figure S10B). To  highlight  inter-omics  relationships,  we  next  performed  correlations  analyses.  The distribution of significant correlations across omics and variables correlations are depicted in Figure 4F-G. The correlation network identified different clusters of variables in which at least one  variable  contributed  to  relapse.  State  8  (TIGIT+KLRG1+2B4+)  in  CM  CD8+  PD1 +CD38- (cluster 28) were correlated with 3-Carboxy-4-methyl-5-propyl-2-furanpropionic acid (3-CMPF), a uremic toxin known to inhibit mitochondrial respiration (Figure 4G).  Altogether  these  results  illustrate  that  among  variables  associated  with  azithromycin intake, Th2 and exhausted T cells, and energy metabolism pathways, notably glycolysis-derived metabolites, contributed specifically to relapse.","prefix":"hed plasmatic pathways included ","suffix":"  Azithromycin intake is associa"}]}]}
>```
>%%
>*%%PREFIX%%hed plasmatic pathways included%%HIGHLIGHT%% ==11/30  (i)  energy  metabolism:  Fatty  Acid  Dicarboxylate,  CoA  Metabolism,  (ii)  immunomodulator mechanisms:  pregnenolone  steroids,  primary  bile  acid,  plasmalog en  and  (iii)  purine  and pyrimidine  metabolism  (Supplemental  Figure S10A).  In  cells,  most  enriched  metabolomic pathways  also  encompassed  energy  metabolism:  MC-FA,  and  dinucleotides  (Supplemental Figure S10B). To  highlight  inter-omics  relationships,  we  next  performed  correlations  analyses.  The distribution of significant correlations across omics and variables correlations are depicted in Figure 4F-G. The correlation network identified different clusters of variables in which at least one  variable  contributed  to  relapse.  State  8  (TIGIT+KLRG1+2B4+)  in  CM  CD8+  PD1 +CD38- (cluster 28) were correlated with 3-Carboxy-4-methyl-5-propyl-2-furanpropionic acid (3-CMPF), a uremic toxin known to inhibit mitochondrial respiration (Figure 4G).  Altogether  these  results  illustrate  that  among  variables  associated  with  azithromycin intake, Th2 and exhausted T cells, and energy metabolism pathways, notably glycolysis-derived metabolites, contributed specifically to relapse.== %%POSTFIX%%Azithromycin intake is associa*
>%%LINK%%[[#^xzgkzj1wir|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^xzgkzj1wir


>%%
>```annotation-json
>{"created":"2022-09-16T13:24:16.912Z","updated":"2022-09-16T13:24:16.912Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":23529,"end":23811},{"type":"TextQuoteSelector","exact":"e  then  performed  single-cell  RNA  sequencing  coupled  with  cellular  indexing  of  epitopes (CITE-seq) on 31 patients’ samples (Figure 5A and Table S9). Clustering 65,382 cells using cell surface antigen expression allowed the identification of 23 immune subsets (Figure 5B-C)","prefix":"ycle and inflammation pathways W","suffix":". Gene set enrichment score was "}]}]}
>```
>%%
>*%%PREFIX%%ycle and inflammation pathways W%%HIGHLIGHT%% ==e  then  performed  single-cell  RNA  sequencing  coupled  with  cellular  indexing  of  epitopes (CITE-seq) on 31 patients’ samples (Figure 5A and Table S9). Clustering 65,382 cells using cell surface antigen expression allowed the identification of 23 immune subsets (Figure 5B-C)== %%POSTFIX%%. Gene set enrichment score was*
>%%LINK%%[[#^ev5sbbyzaka|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^ev5sbbyzaka


>%%
>```annotation-json
>{"created":"2022-09-16T13:26:35.658Z","updated":"2022-09-16T13:26:35.658Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":25513,"end":25771},{"type":"TextQuoteSelector","exact":"To evaluate if azithromycin may have a direct impact on PBMCs and since azithromycin was associated with a lower abundance of T cells and higher frequency of G2M CD4+ T cells, we studied the effects of azithromycin on T cells proliferative functions in vitro","prefix":"ng glycolysis during activation ","suffix":". CD3+-sorted cells from  HD  we"}]}]}
>```
>%%
>*%%PREFIX%%ng glycolysis during activation%%HIGHLIGHT%% ==To evaluate if azithromycin may have a direct impact on PBMCs and since azithromycin was associated with a lower abundance of T cells and higher frequency of G2M CD4+ T cells, we studied the effects of azithromycin on T cells proliferative functions in vitro== %%POSTFIX%%. CD3+-sorted cells from  HD  we*
>%%LINK%%[[#^4tn55wwtur7|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^4tn55wwtur7


>%%
>```annotation-json
>{"created":"2022-09-16T13:27:11.995Z","updated":"2022-09-16T13:27:11.995Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":26336,"end":26454},{"type":"TextQuoteSelector","exact":" This result confirms a specific effect of azithromycin on T cells and is not in favor of a non-specific toxic effect.","prefix":"ation (Supplemental Figure S13).","suffix":" We then treated the cells with "}]}]}
>```
>%%
>*%%PREFIX%%ation (Supplemental Figure S13).%%HIGHLIGHT%% ==This result confirms a specific effect of azithromycin on T cells and is not in favor of a non-specific toxic effect.== %%POSTFIX%%We then treated the cells with*
>%%LINK%%[[#^x3st7p3xql|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^x3st7p3xql


>%%
>```annotation-json
>{"created":"2022-09-16T13:27:30.094Z","updated":"2022-09-16T13:27:30.094Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":26455,"end":26748},{"type":"TextQuoteSelector","exact":"We then treated the cells with cyclosporin A to mimic the effect of GVHD prophylaxis. This revealed that effects of azithromycin and cyclosporin A were additive in CD8+ T cells and that azithromycin at 10 mg.L-1 had an inhibitory effect comparable to cyclosporin at a usual dose of 150 ng.mL-1","prefix":"of a non-specific toxic effect. ","suffix":" (Supplemental Figure S14). Next"}]}]}
>```
>%%
>*%%PREFIX%%of a non-specific toxic effect.%%HIGHLIGHT%% ==We then treated the cells with cyclosporin A to mimic the effect of GVHD prophylaxis. This revealed that effects of azithromycin and cyclosporin A were additive in CD8+ T cells and that azithromycin at 10 mg.L-1 had an inhibitory effect comparable to cyclosporin at a usual dose of 150 ng.mL-1== %%POSTFIX%%(Supplemental Figure S14). Next*
>%%LINK%%[[#^7n9f5o0t2mh|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^7n9f5o0t2mh


>%%
>```annotation-json
>{"created":"2022-09-16T13:27:47.387Z","updated":"2022-09-16T13:27:47.387Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":26776,"end":26947},{"type":"TextQuoteSelector","exact":"Next,  to  assess  if  azithromycin  might  also  affect  cytokine  production  functions,  we studied cytokines levels on T cells supernatant with multiplex immunoassays.","prefix":"mL-1 (Supplemental Figure S14). ","suffix":" After two days of activation,  "}]}]}
>```
>%%
>*%%PREFIX%%mL-1 (Supplemental Figure S14).%%HIGHLIGHT%% ==Next,  to  assess  if  azithromycin  might  also  affect  cytokine  production  functions,  we studied cytokines levels on T cells supernatant with multiplex immunoassays.== %%POSTFIX%%After two days of activation,*
>%%LINK%%[[#^pc98yc88z|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^pc98yc88z


>%%
>```annotation-json
>{"created":"2022-09-16T13:28:10.876Z","updated":"2022-09-16T13:28:10.876Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":27574,"end":27842},{"type":"TextQuoteSelector","exact":"To unravel whether azithromycin could inhibit anti-tumoral T cells cytotoxic functions, anti-CD19  chimeric  antigen  receptor  (CAR)-T  cells  were  cultured  for  24 hours  with azithromycin  then  incubated  with  CD19+  NALM6  lymphoblastic  leukemia  cells  line.","prefix":"trated by a higher IL-13 level. ","suffix":"  The 14/30  percentage  of  spe"}]}]}
>```
>%%
>*%%PREFIX%%trated by a higher IL-13 level.%%HIGHLIGHT%% ==To unravel whether azithromycin could inhibit anti-tumoral T cells cytotoxic functions, anti-CD19  chimeric  antigen  receptor  (CAR)-T  cells  were  cultured  for  24 hours  with azithromycin  then  incubated  with  CD19+  NALM6  lymphoblastic  leukemia  cells  line.== %%POSTFIX%%The 14/30  percentage  of  spe*
>%%LINK%%[[#^3no3dtf7a7c|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^3no3dtf7a7c


>%%
>```annotation-json
>{"created":"2022-09-16T13:28:56.680Z","updated":"2022-09-16T13:28:56.680Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":28029,"end":28773},{"type":"TextQuoteSelector","exact":"Metabolomic  analyses  revealed  enrichment  in  energy  metabolism  pathways  in azithromycin-treated patients and in relapsed patients. We thus hypothesized that azithromycin exposure  could  impair  energy  metabolism  in  T  cells  during  the  immune  response.  Since glycolysis plays a central role in ATP synthesis during T cells activation29, we studied energy metabolism following anti-CD3/CD28 activation in T cells from HD. To characterize the impact of azithromycin on the CD3+ subtypes, CD4+ and CD8+ T cells were sorted and incubated for 24 hours in azithromycin 10 mg.L-1. Glycolytic activity measured by extracellular acidification rate (ECAR) after T cell activation was reduced in CD4+ and CD8+ cells treated by azithromycin ","prefix":"ity (Supplemental Figure S12C). ","suffix":"(Figure 6C).  Mitochondrial  oxi"}]}]}
>```
>%%
>*%%PREFIX%%ity (Supplemental Figure S12C).%%HIGHLIGHT%% ==Metabolomic  analyses  revealed  enrichment  in  energy  metabolism  pathways  in azithromycin-treated patients and in relapsed patients. We thus hypothesized that azithromycin exposure  could  impair  energy  metabolism  in  T  cells  during  the  immune  response.  Since glycolysis plays a central role in ATP synthesis during T cells activation29, we studied energy metabolism following anti-CD3/CD28 activation in T cells from HD. To characterize the impact of azithromycin on the CD3+ subtypes, CD4+ and CD8+ T cells were sorted and incubated for 24 hours in azithromycin 10 mg.L-1. Glycolytic activity measured by extracellular acidification rate (ECAR) after T cell activation was reduced in CD4+ and CD8+ cells treated by azithromycin== %%POSTFIX%%(Figure 6C).  Mitochondrial  oxi*
>%%LINK%%[[#^hyev1kqbcpa|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^hyev1kqbcpa


>%%
>```annotation-json
>{"created":"2022-09-16T13:29:20.405Z","updated":"2022-09-16T13:29:20.405Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":29272,"end":29424},{"type":"TextQuoteSelector","exact":"Using mass cytometry, we studied signaling pathways to evaluate if their inhibition may drive the  dampening  of  glycolysis  and  effector  functions. ","prefix":"g pathways following activation ","suffix":" At  five  time-points  followin"}]}]}
>```
>%%
>*%%PREFIX%%g pathways following activation%%HIGHLIGHT%% ==Using mass cytometry, we studied signaling pathways to evaluate if their inhibition may drive the  dampening  of  glycolysis  and  effector  functions.== %%POSTFIX%%At  five  time-points  followin*
>%%LINK%%[[#^w6zl86vpn8|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^w6zl86vpn8


>%%
>```annotation-json
>{"created":"2022-09-16T13:30:13.838Z","updated":"2022-09-16T13:30:13.838Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":29963,"end":30274},{"type":"TextQuoteSelector","exact":"To  explore  whether  azithromycin's  impact  on  T cells  was  associated  with  phenotypical  and transcriptional changes in CD4+ and CD8+ T cells, we perform CITE-seq on T cells from HD 48 hours  following  anti-CD3/CD28  activation.  Cells  were  clustered  according  to  cell  surface antigen  expression ","prefix":"ts mitochondrial mRNA synthesis ","suffix":" (Figure 7C-D).  Cluster  abunda"}]}]}
>```
>%%
>*%%PREFIX%%ts mitochondrial mRNA synthesis%%HIGHLIGHT%% ==To  explore  whether  azithromycin's  impact  on  T cells  was  associated  with  phenotypical  and transcriptional changes in CD4+ and CD8+ T cells, we perform CITE-seq on T cells from HD 48 hours  following  anti-CD3/CD28  activation.  Cells  were  clustered  according  to  cell  surface antigen  expression== %%POSTFIX%%(Figure 7C-D).  Cluster  abunda*
>%%LINK%%[[#^vth3gu6bomd|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^vth3gu6bomd


>%%
>```annotation-json
>{"created":"2022-09-16T13:30:42.777Z","updated":"2022-09-16T13:30:42.777Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":30385,"end":30977},{"type":"TextQuoteSelector","exact":"Transcriptomic analysis disclosed downregulation of pro-inflammatory genes: (i) IFNG in CD4+, in double-positive central memory (cluster 25) and Th1 (cluster 0) cells, and (ii) MIF in mostly all clusters (Figure 7F and Supplemental Figure S21). SOCS1  was upregulated in most clusters (Figure 7F). Since SOCS1 was recently found to impair anti-tumor response in Th1 cells30, we measured SOCS1 expression six days after activation by flow cytometry. We identified  that  SOCS1  expression  was  significantly  higher  in  azithromycin-treated  CD4+ (p=0.020) but not in CD8+ (p=0.074) T cells ","prefix":"treated conditions (Figure 7E). ","suffix":"(Supplemental Figure S22). Downr"}]}]}
>```
>%%
>*%%PREFIX%%treated conditions (Figure 7E).%%HIGHLIGHT%% ==Transcriptomic analysis disclosed downregulation of pro-inflammatory genes: (i) IFNG in CD4+, in double-positive central memory (cluster 25) and Th1 (cluster 0) cells, and (ii) MIF in mostly all clusters (Figure 7F and Supplemental Figure S21). SOCS1  was upregulated in most clusters (Figure 7F). Since SOCS1 was recently found to impair anti-tumor response in Th1 cells30, we measured SOCS1 expression six days after activation by flow cytometry. We identified  that  SOCS1  expression  was  significantly  higher  in  azithromycin-treated  CD4+ (p=0.020) but not in CD8+ (p=0.074) T cells== %%POSTFIX%%(Supplemental Figure S22). Downr*
>%%LINK%%[[#^kaiycklii5|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^kaiycklii5


>%%
>```annotation-json
>{"created":"2022-09-16T13:31:06.962Z","updated":"2022-09-16T13:31:06.962Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":31981,"end":32290},{"type":"TextQuoteSelector","exact":"Altogether, these results show that azithromycin impairs lymphocyte effector functions through downregulation of mitochondrial complexes I, IV, and V genes and functions, and of genes  with  pro-inflammatory  function  while  it  upregulates  SOCS1  expression,  a  negative regulator of the immune response. ","prefix":"itro (Supplemental Figure S24). ","suffix":" DISCUSSION  Understanding  mech"}]}]}
>```
>%%
>*%%PREFIX%%itro (Supplemental Figure S24).%%HIGHLIGHT%% ==Altogether, these results show that azithromycin impairs lymphocyte effector functions through downregulation of mitochondrial complexes I, IV, and V genes and functions, and of genes  with  pro-inflammatory  function  while  it  upregulates  SOCS1  expression,  a  negative regulator of the immune response.== %%POSTFIX%%DISCUSSION  Understanding  mech*
>%%LINK%%[[#^sqjarc94auq|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^sqjarc94auq


>%%
>```annotation-json
>{"created":"2022-09-16T13:33:19.474Z","updated":"2022-09-16T13:33:19.474Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":36655,"end":36961},{"type":"TextQuoteSelector","exact":"Mitochondria  metabolism  produces  ATP  through  oxidative  phosphorylation  and  metabolites involved  in  the  TCA  and  fatty  acid  oxidation40.  Others  have  already  reported  that  blocking mitochondrial protein translation either leads to decreased cytotoxic and effector functions in T cells44,4","prefix":" respiratory  chain  functions. ","suffix":"5. Since azithromycin is known t"}]}]}
>```
>%%
>*%%PREFIX%%respiratory  chain  functions.%%HIGHLIGHT%% ==Mitochondria  metabolism  produces  ATP  through  oxidative  phosphorylation  and  metabolites involved  in  the  TCA  and  fatty  acid  oxidation40.  Others  have  already  reported  that  blocking mitochondrial protein translation either leads to decreased cytotoxic and effector functions in T cells44,4== %%POSTFIX%%5. Since azithromycin is known t*
>%%LINK%%[[#^d5l193q3r2|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^d5l193q3r2


>%%
>```annotation-json
>{"created":"2022-09-16T13:34:22.308Z","updated":"2022-09-16T13:34:22.308Z","document":{"title":"Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation","link":[{"href":"urn:x-pdf:0e07274f1f72df6be0e39b9b28ce1beb"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf"}],"documentFingerprint":"0e07274f1f72df6be0e39b9b28ce1beb"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010734-main.pdf","selector":[{"type":"TextPositionSelector","start":37780,"end":38618},{"type":"TextQuoteSelector","exact":"antibiotics impact alloreactivity, illustrated by GvHD-related mortality through gut microbiota changes47. Our results highlight that azithromycin directly affects immune cells and  that  these  biological  changes  are  associated  with  relapse  after  allo-HSCT.  Knowing  that GvHD incidence was not modified by azithromycin intake in the trial, the features identified in our  study  (and  in  others)  including:  Th248  and  exhausted  cells17,32,33,  or  metabolically  unfit T cells41 may be more broadly associated with post-transplant relapses mechanisms. Beyond the context of allo-HSCT, azithromycin is widely used in chronic respiratory diseases23. Our results raise  the  question  of  the  safety  of  using  this  treatment  in  patients  at  risk  of  cancer,  such  as chronic obstructive pulmonary disease patients49. ","prefix":"erature  19/30  suggesting that ","suffix":"   20/30  Acknowledgments:  The "}]}]}
>```
>%%
>*%%PREFIX%%erature  19/30  suggesting that%%HIGHLIGHT%% ==antibiotics impact alloreactivity, illustrated by GvHD-related mortality through gut microbiota changes47. Our results highlight that azithromycin directly affects immune cells and  that  these  biological  changes  are  associated  with  relapse  after  allo-HSCT.  Knowing  that GvHD incidence was not modified by azithromycin intake in the trial, the features identified in our  study  (and  in  others)  including:  Th248  and  exhausted  cells17,32,33,  or  metabolically  unfit T cells41 may be more broadly associated with post-transplant relapses mechanisms. Beyond the context of allo-HSCT, azithromycin is widely used in chronic respiratory diseases23. Our results raise  the  question  of  the  safety  of  using  this  treatment  in  patients  at  risk  of  cancer,  such  as chronic obstructive pulmonary disease patients49.== %%POSTFIX%%20/30  Acknowledgments:  The*
>%%LINK%%[[#^h4kcmris1qb|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^h4kcmris1qb
